6/ Two registry moves, plans rather than results. GH Research ended its 5-MeO-DMT aerosol dosing study early, citing its dose-selection aim as met rather than safety. A new single-site trial compares supervised ibogaine with extended-release naltrexone for opioid use disorder.
Full issue and every source 🍄psydao.world/science/2026-10…
PsyDAO retweeted
back when pharma knew how to advertise things well
Readers added context they thought people might want to know
The ad with the child is a satirical fake from the fictional Scarfolk project, not a real historical ad. The other is a genuine 1970s cocaine paraphernalia ad.
scarfolk.blogspot.com/2016/07/drug-a…
en.wikipedia.org/wiki/Scarfolk
allthatsinteresting.com/cocaine-ads-19…
worthpoint.com/worthopedia/19…








